Genital Wart. Anogenital (venereal) warts
Conditions
Interventions
Intervention 1: Intervention group: Volunteers Receive Four Rounds of Oral Vaccine (1 mL) at Weeks 1, 2, 4, and 8. Each Dose of Vaccine Was Administered Orally, Once Each Morning After Fasting For Fiv
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 59 Years
Inclusion criteria
Inclusion criteria: 1- People Voluntarily Participate in the Research. 2- The Informed Consent Form Is Completed and Signed by the Person or Her companion. 3- Women PCR positive test for Papilloma Virus Infection. 4. Women Don't Have other sexually transmitted diseases. Women Don't be Pregnant 6. Women in Pap smear Test Don't Have Abnormal Conditions.
Exclusion criteria
Exclusion criteria: 1. People Don't Have Cancerous Disease During the Course of Treatment. 2. Failure to Complete a Course of Treatment by Individuals Will Result in Their Exclusion from Study. 3- Getting Pregnant During the Course of Treatment Will Leave Women Out of Study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Antibody and Interferon Levels. Timepoint: At the Beginning of the Study, 30, 60 and 90 Days After Taking the Vaccine. Method of measurement: ELISA And ELISPOT KITS. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Hossein Mohseni
Islamic Azad University
Outcome results
None listed